KRAS and ovarian carcinoma: Somatic mutations in the oncogenes KRAS or BRAF usually occur as mutually exclusive events in epithelial ovarian cancer, have been reported in borderline ovarian serous carcinomas or low-grade ovarian serous carcinomas, and occur at a low frequency in HGSCs [33].